Both laparoscopic wedge and endoscopic resection are safe and feasible treatment approaches for patients with gastric ...

Lenvatinib mesylate is under clinical development by Eisai and currently in Phase II for Gastrointestinal Stromal Tumor (GIST). According to GlobalData, Phase II drugs for Gastrointestinal Stromal ...

The tumor grows from the meninges, the membranes (thin layers of tissue) surrounding your brain and spinal cord. Most meningiomas are noncancerous. Meningiomas typically grow slowly, so symptoms ...

the ratio of single to multiple tumors was 30:9. Notably, all SCA with diameters exceeding 10 cm were single lesions (Figure 3D). In conclusion, SCA of the small intestine is a rare but significant ...

as the first mesenchymal stromal cell (MSC) therapy in the United States. RYONCIL is the only MSC therapy approved in the U.S. for any indication, and the only approved therapy for steroid ...

Dec. 18, 2024 /PRNewswire/ -- Today, the U.S. Food and Drug Administration approved Ryoncil (remestemcel-L-rknd), an allogeneic (donor) bone marrow-derived mesenchymal stromal cell (MSC ...

Americans are dangerously ignorant about the symptoms of cancer, research suggests. A recent survey by the Pancreatic Cancer Action Network found eight in 10 adults are unaware of the signs and ...

We systematically collected patient demographics and clinical data, including age, gender, and the symptoms of gastrointestinal hemorrhage ... averaging 61.12 ± 9.14 years in age; and 82 cases of ...

The adaptive single-centre, open-label design for dose-escalation allowed the researchers to safely explore the use of umbilical cord-derived mesenchymal stromal cell therapy in an uncontrolled ...

At present there is no established adjuvant treatment for GIST, but several ongoing studies have explored imatinib in the adjuvant setting. One study randomized patients to receive imatinib or ...